The Mitsubishi Tanabe Pharma Group engages Healthcare Professionals (HCPs) and Healthcare Organisations (HCOs) across Europe.
In accordance with the EFPIA Code of Transfers of Value from Pharmaceutical Companies 2019, details of Transfers of Value made to HCPs and HCOs in Europe by the Mitsubishi Tanabe Pharma Group can be found below.
The methodology applied in preparing and collating this data is available here in English*, French* and German*.
If you are a Healthcare Professional and have any questions regarding the figures disclosed, please contact:
Finance@mt-pharma-eu.com.
2021 Transfers of Value
| Austria | |
|---|---|
| Research & Development | EUR 40,778.84 |
| Non-Research & Development | EUR 48,577.80 |
| Full details here | |
| Belgium | |
|---|---|
| Research & Development | EUR 27,995.79 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Bulgaria | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Croatia | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Cyprus | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Czech Republic | |
|---|---|
| Research & Development | CZK 519,851.60 |
| Non-Research & Development | CZK 0.00 |
| Full details here | |
| Denmark | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Estonia | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Finland | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| France | |
|---|---|
| Research & Development | EUR 856,845.53 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Germany | |
|---|---|
| Research & Development | EUR 453,553.98 |
| Non-Research & Development | EUR 102,665.00 |
| Full details here | |
| Greece | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Hungary | |
|---|---|
| Research & Development | HUF 4,006,692.08 |
| Non-Research & Development | HUF 0.00 |
| Full details here | |
| Ireland | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Italy | |
|---|---|
| Research & Development | EUR 219,476.61 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Latvia | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Lithuania | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Malta | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| The Netherlands | |
|---|---|
| Research & Development | EUR 6,901,213.31 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Norway | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 1,000.00 |
| Full details here | |
| Poland | |
|---|---|
| Research & Development | PLN 763,625.40 |
| Non-Research & Development | PLN 0.00 |
| Full details here | |
| Portugal | |
|---|---|
| Research & Development | EUR 50,611.33 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Romania | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Russia | |
|---|---|
| Research & Development | EUR 137,576.09 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Serbia | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Slovakia | |
|---|---|
| Research & Development | EUR 600.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Slovenia | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Spain | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Sweden | |
|---|---|
| Research & Development | EUR 750.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Switzerland | |
|---|---|
| Research & Development | CHF 16,709.28 |
| Non-Research & Development | CHF 98,164.00 |
| Full details here | |
| Turkey | |
|---|---|
| Research & Development | EUR 0.00 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| Ukraine | |
|---|---|
| Research & Development | EUR 154,057.91 |
| Non-Research & Development | EUR 0.00 |
| Full details here | |
| United Kingdom | |
|---|---|
| Research & Development | GBP 246,849.28 |
| Non-Research & Development | GBP 96,671.68 |
| Full details here or here (ABPI Website) | |
* The Mitsubishi Tanabe Pharma Group has established legal entities in the United Kingdom, Germany and Switzerland and therefore disclosure is made according to local requirements for these countries
Terms and Privacy
Contact Us
Mitsubishi TANABE Pharma Europe Ltd
Dashwood House
69 Old Broad Street
London
EC2M 1QS
United Kingdom